Total Payments
$1,830
2024 Payments
$200.88
Companies
21
Transactions
109
Medicare Patients
8,488
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$1,712 (93.5%)
Education$118.24 (6.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,712 | 107 | 93.5% |
| Education | $118.24 | 2 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $205.92 | 19 | $0 (2023) |
| GENZYME CORPORATION | $200.42 | 10 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $177.57 | 10 | $0 (2019) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $168.86 | 10 | $0 (2020) |
| Allergan, Inc. | $132.27 | 9 | $0 (2020) |
| Lundbeck LLC | $127.05 | 7 | $0 (2019) |
| Eisai Inc. | $110.76 | 6 | $0 (2024) |
| Silk Road Medical, Inc. | $104.22 | 1 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $102.56 | 7 | $0 (2019) |
| ABBVIE INC. | $89.42 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $200.88 | 10 | ARGENX US, INC. ($49.13) |
| 2023 | $228.55 | 20 | Teva Pharmaceuticals USA, Inc. ($170.77) |
| 2020 | $30.21 | 2 | MITSUBISHI TANABE PHARMA AMERICA, INC. ($17.34) |
| 2019 | $506.64 | 27 | Novartis Pharmaceuticals Corporation ($140.55) |
| 2018 | $551.10 | 30 | Silk Road Medical, Inc. ($104.22) |
| 2017 | $312.84 | 20 | Allergan Inc. ($76.93) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Immunology | ||||||
| 05/29/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 05/15/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: NEUROLOGY | ||||||
| 04/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Neurology | ||||||
| 12/06/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: Central Nervous System | ||||||
| 12/01/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: Central Nervous System | ||||||
| 11/08/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: Neurology | ||||||
| 11/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: Central Nervous System | ||||||
| 10/18/2023 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $105.50 | General |
| 10/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: Central Nervous System | ||||||
| 10/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Central Nervous System | ||||||
| 08/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: Central Nervous System | ||||||
| 07/26/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.25 | General |
| Category: Central Nervous System | ||||||
| 06/22/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: Central Nervous System | ||||||
| 06/14/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Central Nervous System | ||||||
| 06/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: Central Nervous System | ||||||
| 05/24/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Central Nervous System | ||||||
| 05/06/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,038 | 3,601 | $540,765 | $331,795 |
| 2022 | 18 | 2,110 | 3,423 | $565,429 | $356,817 |
| 2021 | 20 | 2,275 | 3,732 | $618,106 | $395,646 |
| 2020 | 22 | 2,065 | 6,200 | $724,845 | $344,898 |
Total Patients
8,488
Total Services
16,956
Medicare Billing
$1.4M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 436 | 953 | $190,600 | $131,576 | 69.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 476 | 1,487 | $62,454 | $37,345 | 59.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 102 | 103 | $56,856 | $34,094 | 60.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 144 | 144 | $36,720 | $24,415 | 66.5% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 102 | 106 | $41,128 | $22,479 | 54.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 118 | 119 | $30,345 | $15,544 | 51.2% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 70 | 70 | $24,290 | $13,263 | 54.6% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Office | 2023 | 99 | 99 | $21,780 | $12,194 | 56.0% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 88 | 91 | $15,015 | $8,556 | 57.0% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 82 | 84 | $14,280 | $8,310 | 58.2% |
| 93888 | Ultrasound of within the brain blood flow | Office | 2023 | 61 | 61 | $12,627 | $5,639 | 44.7% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 16 | 33 | $7,260 | $5,432 | 74.8% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Office | 2023 | 85 | 85 | $9,860 | $5,370 | 54.5% |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | Office | 2023 | 36 | 36 | $6,192 | $2,276 | 36.7% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 82 | 82 | $3,936 | $2,054 | 52.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 14 | 14 | $2,366 | $1,270 | 53.7% |
| 64646 | Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | Office | 2023 | 12 | 19 | $3,781 | $1,225 | 32.4% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2023 | 15 | 15 | $1,275 | $754.05 | 59.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 449 | 1,009 | $201,800 | $141,495 | 70.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 145 | 157 | $60,916 | $35,625 | 58.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 98 | 99 | $54,648 | $33,731 | 61.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 460 | 1,161 | $48,804 | $30,395 | 62.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 120 | 120 | $30,600 | $20,604 | 67.3% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 86 | 86 | $29,842 | $17,871 | 59.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 125 | 125 | $31,875 | $16,778 | 52.6% |
About Alfredo Jacome, M.D., P.A
Alfredo Jacome, M.D., P.A is a Neurology healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316996168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alfredo Jacome, M.D., P.A has received a total of $1,830 in payments from pharmaceutical and medical device companies, with $200.88 received in 2024. These payments were reported across 109 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,712).
As a Medicare-enrolled provider, Jacome has provided services to 8,488 Medicare beneficiaries, totaling 16,956 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Summerfield, FL
- Active Since 05/09/2006
- Last Updated 06/16/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1316996168
Products in Payments
- AUBAGIO (Drug) $160.58
- Radicava (Drug) $151.52
- NORTHERA (Drug) $110.32
- ENROUTE Transcarotid Neuroprotection System (Device) $104.22
- NUEDEXTA (Drug) $102.56
- MAYZENT (Drug) $71.83
- Briviact (Drug) $70.71
- AIMOVIG (Biological) $68.72
- Aimovig (Biological) $65.59
- Leqembi (Drug) $64.05
- UBRELVY (Drug) $61.63
- NAMZARIC (Drug) $46.91
- Fycompa (Drug) $46.71
- VRAYLAR (Drug) $46.45
- QULIPTA (Drug) $40.66
- LEMTRADA (Drug) $39.84
- Austedo XR (Drug) $39.54
- GILENYA (Drug) $37.02
- AJOVY (Drug) $35.15
- Trintellix (Drug) $34.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.